146 related articles for article (PubMed ID: 4201309)
1. Formulation of three nitrosoureas for intravenous use.
Davignon JP; Yang KW; Wood HB; Cradock JC
Cancer Chemother Rep 3; 1973 May; 4(3):7-11. PubMed ID: 4201309
[No Abstract] [Full Text] [Related]
2. Nitrosoureas in central nervous system tumors.
Walker MD
Cancer Chemother Rep 3; 1973 May; 4(3):21-6. PubMed ID: 4584033
[No Abstract] [Full Text] [Related]
3. Current status of new agents.
Carter SK
Cancer Chemother Rep 3; 1972 May; 3(1):33-47. PubMed ID: 4116662
[No Abstract] [Full Text] [Related]
4. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
Schein PS; McMenamin MG; Anderson T
Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
[No Abstract] [Full Text] [Related]
5. 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
Carter SK; Schabel FM; Broder LE; Johnston TP
Adv Cancer Res; 1972; 16():273-332. PubMed ID: 4563045
[No Abstract] [Full Text] [Related]
6. Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas.
Wheeler GP; Bowdon BJ; Grimsley JA; Lloyd HH
Cancer Res; 1974 Jan; 34(1):194-200. PubMed ID: 4809457
[No Abstract] [Full Text] [Related]
7. Antitumour activity of a new water-soluble nitrosoureido sugar: CY233 (NSC 609224).
Gosse C; Atassi G; Letourneux Y; Ardouin P; Gouyette A; Fournier JP; Roger P
Anticancer Res; 1988; 8(6):1419-22. PubMed ID: 3218975
[TBL] [Abstract][Full Text] [Related]
8. Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.
Johnston TP; Montgomery JA
Cancer Treat Rep; 1986 Jan; 70(1):13-30. PubMed ID: 2935250
[No Abstract] [Full Text] [Related]
9. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
Moertel CG
Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
[No Abstract] [Full Text] [Related]
10. An overview of the status of the nitrosoureas in other tumors.
Carter SK
Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
[No Abstract] [Full Text] [Related]
11. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
Brunner KW; Maurice P; Sonntag RW
Schweiz Med Wochenschr; 1972 Oct; 102(43):1546-51. PubMed ID: 4647016
[No Abstract] [Full Text] [Related]
12. Early history and development of the nitrosoureas.
Schepartz SA
Cancer Treat Rep; 1976 Jun; 60(6):647-9. PubMed ID: 782693
[No Abstract] [Full Text] [Related]
13. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Frei E; Schabel FM; Goldin A
Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
[No Abstract] [Full Text] [Related]
14. Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia.
Hansch C; Leo A; Schmidt C; Jow PY; Montgomery JA
J Med Chem; 1980 Oct; 23(10):1095-101. PubMed ID: 7420354
[TBL] [Abstract][Full Text] [Related]
15. Toxicology and pharmacology of the nitrosoureas.
Oliverio VT
Cancer Chemother Rep 3; 1973 May; 4(3):13-20. PubMed ID: 4201308
[No Abstract] [Full Text] [Related]
16. Contributions of nitrosoureas to cancer treatment.
Mitchell EP; Schein PS
Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
[No Abstract] [Full Text] [Related]
17. Historical development and future promise of the nitrosoureas as anticancer agents.
Schabel FM
Cancer Chemother Rep 3; 1973 May; 4(3):3-6. PubMed ID: 4584035
[No Abstract] [Full Text] [Related]
18. Synthesis and antitumour activity of several new 4-aroyl-1-nitrosohydrazinecarboxamides.
Gugova R; Topakbashian V; Lozeva S; Dimov S; Golovinsky E
Drugs Exp Clin Res; 1997; 23(2):71-5. PubMed ID: 9309382
[TBL] [Abstract][Full Text] [Related]
19. Fat emulsion vehicle for intravenous administration of an aqueous insoluble drug.
Fortner CL; Grove WR; Bowie D; Walker MD
Am J Hosp Pharm; 1975 Jun; 32(6):582-4. PubMed ID: 1155469
[TBL] [Abstract][Full Text] [Related]
20. [Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU].
Sekido S; Ninomiya K; Araki T; Ueno M; Kinbara M
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1492-500. PubMed ID: 6234861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]